Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David G Rhodes

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Biochimica Et Biophysica Acta|May 15, 2002
Binding of phosphorothioate oligonucleotides to zwitterionic liposomesDongmei Lu, David G Rhodes
Methods in Enzymology|November 7, 2009
Determination of protein purityDavid G Rhodes, Thomas M Laue
Journal of Colloid and Interface Science|November 18, 2005
Multiple emulsion stability: pressure balance and interfacial film strengthJim Jiao, David G Rhodes, Diane J Burgess
The AAPS Journal|March 12, 2005
Anionic liposomal delivery system for DNA transfectionSiddhesh D Patil, David G Rhodes, Diane J Burgess
The AAPS Journal|September 9, 2005
DNA-based therapeutics and DNA delivery systems: a comprehensive reviewSiddhesh D Patil, David G Rhodes, Diane J Burgess
Biochimica Et Biophysica Acta|May 21, 2005
Biophysical characterization of anionic lipoplexesSiddhesh D Patil, David G Rhodes, Diane J Burgess
Methods in Enzymology|November 7, 2009
Determination of size, molecular weight, and presence of subunitsDavid G Rhodes, Robert E Bossio, Thomas M Laue
BMC Biotechnology|November 1, 2012
Pandemic influenza vaccine: characterization of A/California/07/2009 (H1N1) recombinant hemagglutinin protein and insights into H1N1 antigen stabilityElena Feshchenko, David G Rhodes, Rachael Felberbaum, et al.
Vaccine|September 28, 2015
Improved stability of recombinant hemagglutinin using a formulation containing sodium thioglycolateDavid G Rhodes, Kathy Holtz, Pam Robinson, et al.
BMC Biotechnology|December 26, 2014
Modifications of cysteine residues in the transmembrane and cytoplasmic domains of a recombinant hemagglutinin protein prevent cross-linked multimer formation and potency lossKathleen M Holtz, Pamela S Robinson, Erin E Matthews, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Biochimica Et Biophysica Acta|May 15, 2002
Binding of phosphorothioate oligonucleotides to zwitterionic liposomesDongmei Lu, David G Rhodes
Methods in Enzymology|November 7, 2009
Determination of protein purityDavid G Rhodes, Thomas M Laue
Journal of Colloid and Interface Science|November 18, 2005
Multiple emulsion stability: pressure balance and interfacial film strengthJim Jiao, David G Rhodes, Diane J Burgess
The AAPS Journal|March 12, 2005
Anionic liposomal delivery system for DNA transfectionSiddhesh D Patil, David G Rhodes, Diane J Burgess
The AAPS Journal|September 9, 2005
DNA-based therapeutics and DNA delivery systems: a comprehensive reviewSiddhesh D Patil, David G Rhodes, Diane J Burgess
Biochimica Et Biophysica Acta|May 21, 2005
Biophysical characterization of anionic lipoplexesSiddhesh D Patil, David G Rhodes, Diane J Burgess
Methods in Enzymology|November 7, 2009
Determination of size, molecular weight, and presence of subunitsDavid G Rhodes, Robert E Bossio, Thomas M Laue
BMC Biotechnology|November 1, 2012
Pandemic influenza vaccine: characterization of A/California/07/2009 (H1N1) recombinant hemagglutinin protein and insights into H1N1 antigen stabilityElena Feshchenko, David G Rhodes, Rachael Felberbaum, et al.
Vaccine|September 28, 2015
Improved stability of recombinant hemagglutinin using a formulation containing sodium thioglycolateDavid G Rhodes, Kathy Holtz, Pam Robinson, et al.
BMC Biotechnology|December 26, 2014
Modifications of cysteine residues in the transmembrane and cytoplasmic domains of a recombinant hemagglutinin protein prevent cross-linked multimer formation and potency lossKathleen M Holtz, Pamela S Robinson, Erin E Matthews, et al.
Pageof 1